Company: FCRS
Filing Date: 2025-08-05
Form Type: DRS
Source: 0001213900-25-071556
Chunk: 35

Company: FutureCrest Acquisition Corp.
Filing Date: 2025-08-05
Form: DRS
Chunk 35
---
14e-5 under the Exchange Act, which would not be voted in favor of approving the business combination transaction) in favor of our initial business combination. As a result, in addition to our initial shareholders’ founder shares, we would need 8,250,001, or 37.5%, of the 22,000,000 public shares sold in this offering to be voted in favor of an initial business combination in order to have our initial business combination approved, assuming all outstanding shares are voted, the over-allotment option is not exercised and the parties to the letter agreement do not acquire any Class A ordinary shares. Assuming that only the holders of one-third of our issued and outstanding ordinary shares, representing a quorum under our amended and restated memorandum and articles of association, vote their shares at a general meeting of the company, we will not need any public shares in addition to our founder shares to be voted in favor of an initial business combination in order to approve an initial business combination. |
| Private placement warrants: |     | Our sponsor and Cantor Fitzgerald & Co. have committed to purchase an aggregate of 3,200,000 private placement warrants (whether or not the underwriters’ over-allotment option is exercised in full), each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $2.00 per warrant, or $6,400,000 in the aggregate, in a private placement that will close simultaneously with the closing of this offering. Of those 3,200,000 private placement warrants, our sponsor has agreed to purchase 2,100,000 warrants and Cantor Fitzgerald & Co. has agreed to purchase 1,100,000 warrants. The private placement warrants will also be worthless if we do not complete our initial business combination. A portion of the purchase price of the private placement warrants will be added to the proceeds from this offering to be held in the trust account such that at the time of closing of this offering $220,000,000 (or $253,000,000 if the underwriters exercise their over-allotment option in full) will be held in the trust account. The private placement warrants will be                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |

21

|                                                      |     | identical to the warrants sold in this offering except that, so long as they are held by our sponsor or its permitted transferees, the private placement warrants (i) may not (including the Class A ordinary shares iss